**1. Top Risks:**
*   **Undiscovered issues:** All tests passing indicates current coverage is good, but doesn't guarantee all edge cases or complex interactions are covered. The `REVIEW.md` highlights specific areas with potential bugs and technical debt that might not be fully addressed by the existing test suite.
*   **Future regressions:** Without addressing the identified improvement tasks from `TASKS.md`, previously existing issues could re-emerge or new ones could be introduced.

**2. Probable Root Causes:**
*   N/A: No test failures were reported.

**3. Concrete Next Actions:**
*   **Prioritize and address critical/high-priority tasks from `TASKS.md`:** Focus on the issues identified in Phase 1 and Phase 2 of the quality improvement plan.
*   **Review and implement Phase 5 tasks from `TASKS.md`:** Specifically, expanding test coverage (visual regression, fuzzing) and improving documentation accuracy.
*   **Maintain current CI/test status:** Ensure all tests continue to pass as changes are made.
